Status:
RECRUITING
Evaluation of Nasal Non Invasive Ventilation in Management of Neonates With Respiratory Distress Using Lung Ultrasound
Lead Sponsor:
Alexandria University
Conditions:
Preterm
Ventilator Lung; Newborn
Eligibility:
All Genders
1-24 years
Phase:
NA
Brief Summary
This study aims to evaluate the effect of non-invasive ventilation (nIPPV) , (nCPAP), and nasal high flow cannula (NHFC) as a primary mode of ventilation in preterm neonates \<37 gestational week wit...
Eligibility Criteria
Inclusion
- Preterm \<37 wk. gestational age admitted to the NICU with spontaneous breathing and clinical manifestations of RD (tachypnea, nasal flaring, intercostal and subcostal retraction and or grunting).
Exclusion
- Obvious major congenital abnormalities.
- Any of the baby intubated for resuscitation or for other reasons.
- Neonates need invasive mechanical ventilation.
- Pulmonary hemorrhage.
- Severe cardiovascular instability.
- Cardiopulmonary arrest needing prolonged resuscitation.
- Birth asphyxia (one-minute Apgar score ≤ 3).
- Major cardiac diseases (not including patent ductus arteriosus).
Key Trial Info
Start Date :
November 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06550219
Start Date
November 20 2024
End Date
November 1 2025
Last Update
February 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria university, Elshattbi hospital
Alexandria, Egypt, 0354